Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

NCT00389441 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer